ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,195.20
-0.81%
Dow Jones
43,485.25
-0.53%
Gold vs US Dollar
2,645.74
-0.23%
Brent Oil
73.075
-0.79%
Bitcoin
106,867.28
0.74%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Reviva Pharmaceuticals Holdings Inc (RVPH)

  7. Reviva Pharmaceuticals Holdings Inc (RVPH) News

Reviva Pharmaceuticals (RVPH)

Reviva Pharmaceuticals Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RVPH
DateTimeSourceHeadlineSymbolCompany
23/08/202420:06Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
22/08/202421:04Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
22/08/202413:28Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
21/08/202421:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/08/202412:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/08/202412:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
09/07/202413:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
16/02/202421:32Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
13/02/202422:00Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
02/02/202421:38Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
17/11/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
17/11/202321:03Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/11/202321:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/10/202312:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
04/10/202321:19Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
04/10/202321:03Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
04/10/202321:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
17/08/202310:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/08/202320:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/08/202320:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
24/07/202320:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
23/06/202310:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
15/05/202320:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
15/05/202320:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
05/05/202320:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
27/04/202320:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
27/04/202320:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
27/04/202320:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/03/202312:12Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:RVPH

Your Recent History

LSE
SYME
Supply@me Capital
LSE
VAST
Vast Resources
LSE
TM1
Technology Minerals
LSE
POS
Plexus
LSE
CPI
Capita
LSE
AXL
Arrow Exploration
LSE
NFDS
Northern Foods
LSE
QBT
Quantum Blockchain Techn...
LSE
SBTX
Skinbiotherapeutics
LSE
TW.
Taylor Wimpey
LSE
AAZ
Anglo Asian Mining
LSE
HVO
Hvivo
LSE
NESF
Nextenergy Solar
LSE
ENET
Ethernity Networks
LSE
GGP
Greatland Gold
LSE
SCLP
Scancell
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved